Zobrazeno 1 - 10 of 55 pro vyhledávání: '"Paolo Zucali"'
1
Akademický článek
hMENA isoforms regulate cancer intrinsic type I IFN signaling and extrinsic mechanisms of resistance to immune checkpoint blockade in NSCLC
Autor: Sarah Warren, Paola Nisticò, Federico Cappuzzo, Federica Marchesi, Isabella Sperduti, Silvia Carpano, Francesca De Nicola, Frauke Goeman, Lorenzo D'Ambrosio, Vanesa Gregorc, Claudio Tripodo, Vincenzo Russo, Paolo Visca, Francesca Paolini, Paola Trono, Annalisa Tocci, Belinda Palermo, Anna Di Carlo, Daniel D'Andrea, Francesca Di Modugno, Giacomo Corleone, Mariangela Panetta, Silvia Baldari, Paolo Zucali
Publikováno v: Journal for ImmunoTherapy of Cancer, Vol 11, Iss 8 (2023)
Background Understanding how cancer signaling pathways promote an immunosuppressive program which sustains acquired or primary resistance to immune checkpoint blockade (ICB) is a crucial step in improving immunotherapy efficacy. Among the pathways th
Externí odkaz: https://doaj.org/article/fd3fa3f807bf4ff6ad2b89290cb99193
Zobrazit plný text záznamu
2
Akademický článek
Prediction of vertebral fractures in cancer patients undergoing hormone deprivation therapies: Reliability of WHO fracture risk assessment tool (FRAX) and bone mineral density in real-life clinical practice
Autor: Gherardo Mazziotti, Walter Vena, Rebecca Pedersini, Sara Piccini, Emanuela Morenghi, Deborah Cosentini, Paolo Zucali, Rosalba Torrisi, Silvio Sporeni, Edda L. Simoncini, Roberto Maroldi, Luca Balzarini, Andrea G. Lania, Alfredo Berruti
Publikováno v: Journal of Bone Oncology, Vol 33, Iss , Pp 100421- (2022)
Background and Objective: Prediction of fractures in cancer survivors exposed to hormone-deprivation therapies (HDTs) is a challenge since bone loss is rapid and severe, and determinants of fractures in this setting are still largely unknown. In this
Externí odkaz: https://doaj.org/article/ef3dbe48af154edd868ecf7a3bd515b1
Zobrazit plný text záznamu
6
Intratumoral Switch of Molecular Phenotype and Overall Survival in Muscle Invasive Bladder Cancer
Autor: Camilla De Carlo, Marina Valeri, Noemi Rudini, Paolo Zucali, Miriam Cieri, Grazia Elefante, Federica D’antonio, Rodolfo Hurle, Laura Giordano, Alessandra Bressan, Massimo Lazzeri, Matteo Perrino, Giorgio Guazzoni, Luigi Terracciano, Piergiuseppe Colombo
Publikováno v: Cancers; Volume 14; Issue 13; Pages: 3256
In recent years, immunohistochemical protein expression was studied as a surrogate to the molecular classification of bladder cancer, although no tissue biomarkers are available for clinical use to predict survival or the response to neoadjuvant chem
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::593af546b158cfee859437ba13fd9feb
https://doi.org/10.3390/cancers14133256
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje